Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives

Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives

Fungal diseases affect more than 1 billion people worldwide. The constant global changes, the advent of new pandemics, and chronic diseases favor the diffusion of fungal pathogens such as <i>Candida</i>, <i>Cryptococcus</i>, <i>Aspergillus</i>, <i>Trichophyt...

Full description

Bibliographic Details
Main Authors:	Carolina Orlando Vaso, Fabiana Pandolfi, Níura Madalena Bila, Daniela De Vita, Martina Bortolami, Maria José Soares Mendes-Giannini, Valeria Tudino, Roberta Costi, Caroline Barcelos Costa-Orlandi, Ana Marisa Fusco-Almeida, Luigi Scipione
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Pharmaceutics
Subjects:	broad-spectrum antifungal nitrofuran derivates antifungal activity <i>Candida</i> sp. <i>Cryptococcus neoformans</i> <i>Histoplasma capsulatum</i>
Online Access:	https://www.mdpi.com/1999-4923/14/3/593

Similar Items

Evaluation of the Anti-<i>Histoplasma capsulatum</i> Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures
by: Carolina Orlando Vaso, et al.
Published: (2022-05-01)

Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
by: Ines Joao, et al.
Published: (2020-11-01)

<i>Cryptococcus neoformans</i> Causing Meningoencephalitis in Adults and a Child from Lima, Peru: Genotypic Diversity and Antifungal Susceptibility
by: Carolina Firacative, et al.
Published: (2022-12-01)

First Isolation, Antifungal Susceptibility, and Molecular Characterization of <i>Cryptococcus neoformans</i> from the Environment in Croatia
by: Donjeta Pllana-Hajdari, et al.
Published: (2019-10-01)

Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020
by: Spinello Antinori, et al.
Published: (2021-06-01)

Fungicidal Activity of Recombinant Javanicin against <i>Cryptococcus neoformans</i> Is Associated with Intracellular Target(s) Involved in Carbohydrate and Energy Metabolic Processes
by: Santhasiri Orrapin, et al.
Published: (2021-11-01)

Influence of Galectin-3 on the Innate Immune Response during Experimental Cryptococcosis
by: Caroline Patini Rezende, et al.
Published: (2021-06-01)

Kinase Inhibitor Library Screening Identifies the Cancer Therapeutic Sorafenib and Structurally Similar Compounds as Strong Inhibitors of the Fungal Pathogen <i>Histoplasma capsulatum</i>
by: Charlotte Berkes, et al.
Published: (2021-10-01)

Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen, <i>Cryptococcus neoformans</i>
by: Kwang-Woo Jung, et al.
Published: (2021-06-01)

A Fatal Case of Disseminated Histoplasmosis by <i>Histoplasma capsulatum</i> var. <i>capsulatum</i> Misdiagnosed as Visceral Leishmaniasis—Molecular Diagnosis and Identification
by: Manuel Calvopiña, et al.
Published: (2023-08-01)

In Vitro Antifungal Activity of Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II against <i>Cryptococcus neoformans</i> var. <i>grubii</i>
by: Silvia Katherine Carvajal, et al.
Published: (2022-12-01)

Antifungal Potential of Synthetic Peptides against <i>Cryptococcus neoformans</i>: Mechanism of Action Studies Reveal Synthetic Peptides Induce Membrane–Pore Formation, DNA Degradation, and Apoptosis
by: Tawanny K. B. Aguiar, et al.
Published: (2022-08-01)

Differential miRNA Expression in Human Macrophage-Like Cells Infected with <i>Histoplasma capsulatum</i> Yeasts Cultured in Planktonic and Biofilm Forms
by: Nayla de Souza Pitangui, et al.
Published: (2021-01-01)

Remodeling of the <i>Histoplasma Capsulatum</i> Membrane Induced by Monoclonal Antibodies
by: Meagan C. Burnet, et al.
Published: (2020-06-01)

A Phylogeographic Description of <i>Histoplasma capsulatum</i> in the United States
by: Ujwal R. Bagal, et al.
Published: (2023-08-01)

Development of a Real-Time PCR Assay to Identify and Distinguish between <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> Species Complexes
by: Enoch Tay, et al.
Published: (2022-04-01)

Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
by: Kathleen A. Linder, et al.
Published: (2020-12-01)

Antifungal Activity of Soil Streptomyces Isolates Against Cryptococcus neoformans
by: Başaran Dülger, et al.
Published: (2021-04-01)

The Antidepressant Sertraline Induces the Formation of Supersized Lipid Droplets in the Human Pathogen <i>Cryptococcus neoformans</i>
by: Matthew R. Breuer, et al.
Published: (2022-06-01)

Environmental Status of <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> in Colombia
by: Briggith-Nathalia Serna-Espinosa, et al.
Published: (2021-05-01)

Experience of varied presentation of chronic progressive disseminated histoplasmosis in immunocompetent patients: A diagnostic conundrum
by: Roumi Ghosh, et al.
Published: (2016-01-01)

Biofilm Formation by Histoplasma capsulatum in Different Culture Media and Oxygen Atmospheres
by: Larissa Naiara Carvalho Gonçalves, et al.
Published: (2020-07-01)

Traversing the Cell Wall: The Chitinolytic Activity of <i>Histoplasma capsulatum</i> Extracellular Vesicles Facilitates Their Release
by: Alessandro F. Valdez, et al.
Published: (2023-10-01)

Acute Pulmonary Histoplasmosis Following COVID-19: Novel Laboratorial Methods Aiding Diagnosis
by: Priscila Marques de Macedo, et al.
Published: (2021-04-01)

Exploring <i>Cryptococcus neoformans</i> CYP51 and Its Cognate Reductase as a Drug Target
by: Yasmeen N. Ruma, et al.
Published: (2022-11-01)

The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of <i>Cryptococcus neoformans</i>
by: Mahek Momin, et al.
Published: (2021-06-01)

Central Nervous System Cryptococcal Infections in Non-HIV Infected Patients
by: Justin Beardsley, et al.
Published: (2019-08-01)

Ergosterol Is Critical for Sporogenesis in <i>Cryptococcus neoformans</i>
by: Amber R. Matha, et al.
Published: (2024-01-01)

Nutritional Conditions Modulate <i>C. neoformans</i> Extracellular Vesicles’ Capacity to Elicit Host Immune Response
by: Clara Luna Marina, et al.
Published: (2020-11-01)

Application of Real-Time PCR Assays for the Diagnosis of Histoplasmosis in Human FFPE Tissues Using Three Molecular Targets
by: Luisa F. López, et al.
Published: (2023-06-01)

<i>Cryptococcus</i>: History, Epidemiology and Immune Evasion
by: Israel Diniz-Lima, et al.
Published: (2022-07-01)

Cerebral Cryptococcomas: A Systematic Scoping Review of Available Evidence to Facilitate Diagnosis and Treatment
by: Daniel B. Chastain, et al.
Published: (2022-02-01)

Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein
by: Nozethu Mjokane, et al.
Published: (2022-01-01)

Antifungal Drug Repurposing
by: Jong H. Kim, et al.
Published: (2020-11-01)

Indoor Dust as a Source of Virulent Strains of the Agents of Cryptococcosis in the Rio Negro Micro-Region of the Brazilian Amazon
by: Fábio Brito-Santos, et al.
Published: (2020-05-01)

Simplified All-In-One CRISPR-Cas9 Construction for Efficient Genome Editing in <i>Cryptococcus</i> Species
by: Ping Zhang, et al.
Published: (2021-06-01)

3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine <i>N</i>-acetyltransferase, in Mycobacteria
by: Neha Agre, et al.
Published: (2020-07-01)

Closing the Gap in Proteomic Identification of <i>Histoplasma capsulatum</i>: A Case Report and Review of Literature
by: Terenzio Cosio, et al.
Published: (2023-10-01)

<i>RTA1</i> Is Involved in Resistance to 7-Aminocholesterol and Secretion of Fungal Proteins in <i>Cryptococcus neoformans</i>
by: Emily S. Smith-Peavler, et al.
Published: (2022-10-01)

Exposure of <i>Cryptococcus neoformans</i> to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
by: Pascal Drakulovski, et al.
Published: (2023-04-01)